{"id":210819,"title":"Archived 48: Summary of NACI statement of December 9, 2022: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T12:16:25.407000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccine-booster-doses-children-5-11-years-concurrent-administration/summary-december-9-2022.html","snippet":"Archived 48: Summary of NACI statement of December 9, 2022: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration - Canada.ca Skip to main content Skip to \"About government\" We have archived…","rawSnapshotUrl":"/api/snapshots/raw/210819","browseUrl":"https://replay.healtharchive.ca/job-1/20250418121625/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccine-booster-doses-children-5-11-years-concurrent-administration/summary-december-9-2022.html#ha_snapshot=210819","mimeType":"text/html","statusCode":200}